Oltmann Siemens, Famed International Banker and Economic Counselor, Joins C-MCC Development Group, LLC as Vice Chairman
The former representative of the World Bank brings a unique perspective to the Company's major trade and financial initiative in Curacao
NEW YORK, Oct. 12, 2017 (GLOBE NEWSWIRE) -- The C-MCC Development Group have announced that Oltmann Siemens, the eminent Jurist, Banker and Economic Counselor to many countries, has joined the company as Vice Chairman.
The C-MCC Development Group LLC, which is based in the U.S. and Curacao, has extensive experience in real estate development, technology, security and international commodities trading. It is the holding company of the Curacao Multi-Commodities Centre Worldwide Free Trade Zone, the first of its kind in the Western hemisphere. It will establish Curacao as a premier international trade development hub and gateway to the world's markets.
In making the announcement today, George Kearns, Chairman and CEO of C-MCC said, Oltmann Siemens has helped shape today's European business and financial interaction. "His achievements are inspiring and his interaction with governments and international business banking will add considerably to our endeavors to make Curacao the epicenter of trade and finance in this Hemisphere."
"His experience over several years in working with a number of governments including that of the U.S., together with international business and financial leaders, will help C-MCC identify the opportunities which lie ahead. He is a valuable asset to us in today's volatile global economic environment. We are privileged to have him join us."
The Chairman's comments were echoed by Dr. I. S. Steven Martina, Curacao's Minister of Economic Development, who said, Oltmann Siemens reputation precedes him. "My Government is intent on bringing international investment to Curacao, so for this and so many other reasons, we are delighted Oltmann has agreed to join the Board of C-MCC Development Group as its Vice Chairman. His unique worldwide perspective as a preeminent Jurist and International Banker, together with his interaction with world business leaders, will help accelerate the efforts of C-MCC and my government to place Curacao at the very forefront of regional trade and financial services."
In thanking the Minister and Chairman, George Kearns, Mr. Siemens said, "I am honored to have this opportunity to play a strategic role within a thoroughly aware and forward looking company like the C-MCC. We conduct our business in a world of seemingly instantaneous communication. The management of C-MCC, in their endeavors to create a dynamic all encompassing trade and distributive centre in Curacao, has embraced some of the most highly developed communications and trading tools to create an engine to provide a common regulatory global market and boost trade for the benefit of all. I admire this greatly and I am so very pleased to join them in establishing Curacao as a premier financial centre in the Western Hemisphere - one that will revolutionize business and economic growth in the region. Again, I am so very pleased to join this group of dedicated business leaders."
C-MCC Worldwide is a free trade zone initiative that will provide an ecosystem to facilitate physical, commodity trading, financial, technological and regulatory services through Curacao. It is the first free zone entity of its kind in the western hemisphere that will establish Curacao as the premier international trade development hub and gateway to the world. The establishment of the C-MCC will reduce political and economic risk and revolutionize the growth of trade, business and communities in many regions of the world.
|Christina Sitlani, Director Marketing||Victor Webb|
|C-MCC Worldwide||Marston Webb International|
|T: (347) 529-9344||T: (212) 684-6601|
|e-mail: Christina.Sitlani@c-mcc.com||e-mail: firstname.lastname@example.org|
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: C-MCC Development Group, LLC via Globenewswire
Följ NASDAQ OMX
Skriv in din e-postadress så får du ett mejl när vi har något nytt att berätta.
Senaste pressmeddelandena från NASDAQ OMX
Barings Supports New Mountain Capital Investment in DRB Systems17.10.2017 16:30 | Pressmeddelande
CHARLOTTE, N.C., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Barings, one of the world's leading asset management firms, announced today that it served as a Joint Lead Arranger on a Senior Secured Credit Facility to support New Mountain Capital's acquisition of DRB Systems LLC. Founded in 1984 and based in Akron, Ohio, DRB Systems is the leading provider of turnkey technology solutions used to enhance the operational efficiency of car wash sites across the U.S. DRB's integrated technology offering includes hardware and software used in point-of-sale and tunnel control systems as well as ancillary modules to support marketing, human resources, and business analytics. "New Mountain Capital is pleased to have completed its investment in DRB Systems," said Jack Qian, Director of New Mountain Capital. Laura Holson, Head of Capital Markets at New Mountain added, "We deeply value Barings' support as a financing pa
Crown Bioscience to Showcase Scientific Expertise in Preclinical Evaluation of Investigational Cancer Compounds17.10.2017 16:12 | Pressmeddelande
SANTA CLARA, Calif., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, will showcase their scientific expertise at this year's American Association for Cancer Research's International Conference on Molecular Targets and Cancer Therapeutics (AACR-NCI-EORTC) October 26th through the 30th. CrownBio's scientists will present 13 scientific posters describing their latest research efforts, including generation of novel models for combinatory chemotherapy and immunotherapy studies, creation of 3D screening panels for improved efficacy assessments, demonstration of a checkpoint immunotherapy modulating intestinal microbiota, among other innovative developments in cancer therapeutics and preclinical pharmacology evaluation. On
Oxford Immunotec Schedules Third Quarter 2017 Earnings Release and Conference Call for October 31, 201717.10.2017 15:15 | Pressmeddelande
OXFORD, United Kingdom and MARLBOROUGH, Mass., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced that it plans to release third quarter 2017 financial results prior to market open on Tuesday, October 31, 2017. Dr. Peter Wrighton-Smith, Chief Executive Officer, and Rick Altieri, Chief Financial Officer, will host a conference call to review the Company's results at 8:00 a.m. Eastern Time the same day. The call will be concurrently webcast. To listen to the conference call on your telephone, please dial (855) 363-5047 for United States callers and +1 (484) 365-2897 for international callers and reference confirmation code 99539511, approximately ten minutes prior to start time. To access the live audio webcast or subsequent archived recording, visit the Investor Relations se
World Conference on Lung Cancer Tuesday Press Conference: Evidence to Support Innovative Lung Cancer Interventions17.10.2017 08:16 | Pressmeddelande
YOKOHAMA, Japan, Oct. 17, 2017 (GLOBE NEWSWIRE) -- Today's press conference at the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC) featured groundbreaking findings in the study of both small cell and non-small cell lung cancer. The studies presented covered broad research areas, from confirmation of existing classification criteria to ensuring viability of evidence to supporting the use of specific interventions. Biopsy specimen found to be reliable for evaluating DLL3 expression in small cell lung cancer Small cell lung cancer (SCLC) biopsy specimen was found to be reliable material for evaluating DLL3 expression; high levels of DLL3 in SCLC are correlated with poor survival trends. These results may lead to further evaluation of the scoring system for predicting DLL3-targeted therapeutic efficacy and clinical significance of DLL3 expression in high-grade pulmonary neuroendocrine carcinomas.
New Era Launches Direct-to-Consumer eCommerce Site Built by EPAM and Powered with SAP Hybris17.10.2017 06:01 | Pressmeddelande
New Site Expands Headwear and Apparel Offering with Immersive, Omnichannel Experience NEWTOWN, Pa., Oct. 17, 2017 (GLOBE NEWSWIRE) -- EPAM Systems, Inc. (NYSE:EPAM), a leading global provider of digital platform engineering and software development services, and New Era, a global headwear brand rooted in sports, today announced the launch of New Era's first direct-to-consumer website, neweracap.com. New Era's B2B business remains strong, and the company is now putting an emphasis on selling its products directly to customers and expanding its offering into the lifestyle market. The new site offers products for seasoned athletes and sports fans, as well as street and lifestyle consumers. "In an age where businesses cannot tolerate lengthy, scope changing technology projects, EPAM quickly established themselves as the standout partner for us to tackle this ambitious initiative," said Lorenz Gan, Global Vice President, Information Technology, New Era. "Whilst this p
CP Kelco Appoints Didier Viala as New President16.10.2017 15:00 | Pressmeddelande
ATLANTA, Oct. 16, 2017 (GLOBE NEWSWIRE) -- CP Kelco, a leading global producer of specialty hydrocolloid solutions, announced today that Didier Viala has been appointed President, effective October 1, 2017. Viala replaces Donald Rubright, who served as CP Kelco President since 2006 and will retire at the end of 2017. Viala has also joined the CP Kelco Board of Directors. "As a market leader supplying high-quality hydrocolloid products for a range of foods and beverages, consumer products and industrial applications, CP Kelco will continue to invest in capacity additions, new product and applications development, strategic raw material sourcing, quality and safety management, and sustainability initiatives to support our customers' innovation efforts and growth strategies," Viala said. Over the course of more than 25 years with CP Kelco and its predecessor companies, Viala held leadership roles across a broad spectrum of critical areas, including innovat
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.Besök vårt pressrum